Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Cardiol. Apr 26, 2011; 3(4): 111-116
Published online Apr 26, 2011. doi: 10.4330/wjc.v3.i4.111
Table 1 Body weight, systolic blood pressure, biochemical and echocardiographic data of rats at baseline (n = 16) (mean ± SD)
WCL
Body weight (g)390 ± 6393 ± 6395 ± 5
SBP (mmHg)127 ± 7127 ± 10120 ± 11
Glucose (mg/dL)110 ± 3112 ± 3111 ± 3
Triglycerides (mg/dL)72 ± 970 ± 1072 ± 8
LVDD (mm)6.2 ± 0.56.3 ± 0.66.8 ± 0.5
RWTh0.34 ± 0.060.37 ± 0.030.34 ± 0.06
ESD (mm)2.7 ± 0.52.7 ± 0.53.3 ± 0.5
IVSd (mm)0.84 ± 0.150.93 ± 0.090.91 ± 0.12
LVPWd (mm)1.2 ± 0.21.4 ± 0.11.4 ± 0.3
LVPWs (mm)2.6 ± 0.42.6 ± 0.42.6 ± 0.3
HR (bpm)447 ± 45421 ± 69425 ± 49
Aorta (mm)2.7 ± 0.12.9 ± 0.32.8 ± 0.4
LA (mm)2.5 ± 0.32.7 ± 0.62.8 ± 0.4
Sf (%)55.6 ± 6.956.8 ± 8.851.7 ± 4.9
EDV (mL)0.21 ± 0.050.22 ± 0.060.27 ± 0.06
ESV (mL)0.02 ± 0.010.02 ± 0.010.03 ± 0.01
Ef (%)90.7 ± 3.791.0 ± 5.588.4 ± 3.5
SV (mL)0.19 ± 0.050.20 ± 0.060.24 ± 0.05
CO (mL/min)83.2 ± 20.185.5 ± 32.2288.6 ± 23.8
Table 2 Body weight and nutritional facts (food, liquid, calories and sodium daily intake per 100 g body weight) after treatment and washout periods (mean ± SD)
Treatment (6 mo)
Washout (12 mo)
W6 (n = 15)C6 (n = 14)L6 (n = 15)W12 (n = 7)C12 (n = 6)L12 (n = 8)
Body Weight (g)626 ± 8669 ± 9b630 ± 9689 ± 10d703 ± 27699 ± 61
Intake (mL or g/100 g BW)
Liquid8.7 ± 1.214.7 ± 2.8c8.5 ± 1.77.1 ± 1.111.3 ± 1.8cd6.5 ± 1.5
Solid4.9 ± 0.63.4 ± 0.6c5.1 ± 0.45.5 ± 0.63.8 ± 0.6a4.9 ± 0.6a
Energy (Kcal/100 g BW)
Liquid06.17 ± 0.5c0.09 ± 0.00000
Solid14.7 ± 1.1 10.2 ± 1.315.3 ± 0.916.5 ± 1.011.4 ± 0.914.7 ± 0.9
Total14.7 ± 1.116.4 ± 1.2b15.4 ± 0.916.5 ± 1.511.4 ± 1.1d14.7 ± 0.9
Sodium (mg/100 g BW)
Liquid00.59 ± 0.2c0.34 ± 0.1c000
Solid9.8 ± 1.06.8 ± 0.7a10.2 ± 0.911.0 ± 0.17.6 ± 0.79.8 ± 1.0
Total9.8 ± 1.07.4 ± 1.210.5 ± 1.011.0 ± 0.17.6 ± 0.7a9.8 ± 1.0
Table 3 Systolic blood pressure and biochemical data at 6 and 12 mo (mean ± SD)
Treatment (6 mo)
Washout (12 mo)
W (n = 15)C (n = 14)L (n = 15)W (n = 7)C (n = 6)L (n = 8)
SBP (mmHg)134 ± 2 145 ± 3b135.5 ± 2131 ± 9142.5 ± 15144 ± 8
Glycemia (mg/dL)128 ± 3139 ± 3a126 ± 3128 ± 10.5127 ± 34119 ± 16
Triglyceridemia (mg/dL)90 ± 9c196 ± 24b107 ± 20132 ± 73206.5 ± 77a149 ± 60
Table 4 Echocardiographic parameters at 6 and 12 mo (mean ± SD)
Treatment (6 mo)
Washout (12 mo)
W (n = 15)C (n = 14)L (n = 15)W (n = 7)C (n = 6)L (n = 8)
LVDD (mm)6.8 ± 0.47.4 ± 0.3a7.3 ± 0.5a7.2 ± 0.57.4 ± 0.47.8 ± 0.6
RWTh0.40 ± 0.03c0.37 ± 0.03a0.36 ± 0.05a0.35 ± 0.040.36 ± 0.020.35 ± 0.04
ESD (mm)2.7 ± 0.5c3.1 ± 0.63.1 ± 0.53.4 ± 0.43.4 ± 0.43.2 ± 0.3
IVSd (mm)1.2 ± 0.11.1 ± 0.11.1 ± 0.11.1 ± 0.11.1 ± 0.11.1 ± 0.1
LVPWd (mm)1.6 ± 0.11.6 ± 0.11.5 ± 0.21.4 ± 0.11.6 ± 0.21.6 ± 0.1
LVPWs (mm)3.6 ± 0.63.6 ± 0.63.1 ± 0.63.7 ± 0.43.1 ± 0.53.7 ± 0.5
HR (bpm)469 ± 36470 ± 46457 ± 44469 ± 23472 ± 26452 ± 52
Aorta (mm)3.5 ± 0.33.5 ± 0.33.5 ± 0.33.4 ± 0.23.4 ± 0.23.6 ± 0.1
LA (mm)3.3 ± 0.33.4 ± 0.43.2 ± 0.43.3 ± 0.33.4 ± 0.53.3 ± 0.2
Sf (%)59.9 ± 7.258.5 ± 8.657.2 ± 7.452.1 ± 4.654.3 ± 6.358.9 ± 2.9
EDV (mL)0.27 ± 0.040.34 ± 0.04b0.33 ± 0.06ac0.32 ± 0.060.34 ± 0.060.41 ± 0.09b
ESV (mL)0.02 ± 0.010.03 ± 0.020.03 ± 0.020.04 ± 0.010.03 ± 0.010.03 ± 0.01
Ef (%)93.0 ± 492.0 ± 4.991.5 ± 3.888.8 ± 2.990.1 ± 3.792.9 ± 1.4
SV (mL)0.25 ± 0.040.31 ± 0.04a0.31 ± 0.07a0.28 ± 0.060.31 ± 0.070.37 ± 0.08a
CO (mL/min)118 ± 21148 ± 21a138.5 ± 33132 ± 26146 ± 29172 ± 46